• Advertise
  • Contact Us
  • About Us
  • Supplier Directory
  • SCB YouTube
  • Login
  • Subscribe
  • Logout
  • My Profile

  • CORONAVIRUS
  • LOGISTICS
    • Air Cargo
    • All Logistics
    • Express/Small Shipments
    • Facility Location Planning
    • Freight Forwarding/Customs Brokerage
    • Global Gateways
    • Global Logistics
    • Last Mile Delivery
    • Logistics Outsourcing
    • LTL/Truckload Services
    • Ocean Transportation
    • Rail & Intermodal
    • Reverse Logistics
    • Service Parts Management
    • Transportation & Distribution
  • TECHNOLOGY
    • All Technology
    • Artificial Intelligence
    • Cloud & On-Demand Systems
    • Data Management (Big Data/IoT/Blockchain)
    • ERP & Enterprise Systems
    • Forecasting & Demand Planning
    • Global Trade Management
    • Inventory Planning/ Optimization
    • Product Lifecycle Management
    • Sales & Operations Planning
    • SC Finance & Revenue Management
    • SC Planning & Optimization
    • Sourcing/Procurement/SRM
    • Supply Chain Visibility
    • Transportation Management
  • GENERAL SCM
    • Business Strategy Alignment
    • Education & Professional Development
    • Global Supply Chain Management
    • Global Trade & Economics
    • HR & Labor Management
    • Quality & Metrics
    • Regulation & Compliance
    • SC Security & Risk Mgmt
    • Supply Chains in Crisis
    • Sustainability & Corporate Social Responsibility
  • WAREHOUSING
    • All Warehouse Services
    • Conveyors & Sortation
    • Lift Trucks & AGVs
    • Order Fulfillment
    • Packaging
    • RFID, Barcode, Mobility & Voice
    • Robotics
    • Warehouse Management Systems
  • INDUSTRIES
    • Aerospace & Defense
    • Apparel
    • Automotive
    • Chemicals & Energy
    • Consumer Packaged Goods
    • E-Commerce/Omni-Channel
    • Food & Beverage
    • Healthcare
    • High-Tech/Electronics
    • Industrial Manufacturing
    • Pharmaceutical/Biotech
    • Retail
  • REGIONS
    • Asia Pacific
    • Canada
    • China
    • Europe
    • Latin America
    • Middle East/Africa
    • North America
  • THINK TANK
  • WEBINARS
    • On-Demand Webinars
    • Upcoming Webinars
  • PODCASTS
  • VIDEOS
  • WHITEPAPERS
Home » Health Agencies Set Stage for U.S. to Import Cheaper Drugs

Health Agencies Set Stage for U.S. to Import Cheaper Drugs

Health Agencies Set Stage for U.S. to Import Cheaper Drugs
August 1, 2019
Bloomberg

The Trump administration cracked open the door for the eventual importation of cheaper medicines from abroad, the latest salvo in a battle to bring down drug costs.

The U.S. Department of Health and Human Services and the Food and Drug Administration on Wednesday published what they dubbed a “safe importation action plan” that could allow for certain medications originally intended for foreign markets to be sold to U.S. consumers.

Importing cheaper medicines from abroad is an idea that has attracted increased bipartisan support amid a wider campaign to control the price of prescription drugs. President Donald Trump has backed the idea, as have some Democratic presidential candidates including Senator Bernie Sanders of Vermont.

Critics have said that allowing medicines from other countries to be sold in the U.S. could endanger public health and safety, but Health Secretary Alex Azar said he’s seen changes in the global supply chain that warrant a shift in perspective.

“We’ve seen pharmacy chains similarly expand across American borders, giving a much more business to business potentiality here for importation and safe management of the drug supply chain,” Azar said during a conference call with reporters. “We’ve seen enhanced regulatory frameworks be implemented such as track and trace, which did not exist when this issue was last fully considered back in the Bush administration.”

The pharmaceutical industry quickly rejected the idea. Stephen Ubl, chief executive officer of the trade group PhRMA, said the importation plan is too dangerous and that the administration should focus on reducing patients’ out-of-pocket costs.

“Drugs coming through Canada could have originated from anywhere in the world and may not have undergone stringent review by the FDA,” Ubl said in a statement. “Law enforcement has repeatedly warned that importation schemes could worsen the opioid crisis and jeopardize public safety. Moreover, Canadian officials have said that the policy is unworkable, and they will not risk shortages by diverting their medicine supply to the United States.”

Alexander Cohen, a spokesman for Canadian Health Minister Ginette Petitpas Taylor, said Canadian officials are in contact with their U.S. counterparts to discuss Wednesday’s announcement.

Canadian officials “will be working closely with health experts to better understand the implications for Canadians and will ensure there are no adverse effects to the supply or cost of prescription drugs in Canada,” Cohen said.

Pilot Projects

Under the plan released on Wednesday, the administration will propose a rule that would authorize pilot projects developed by states, wholesalers or pharmacists outlining how they would import certain drugs from Canada that are versions of FDA-approved medicines.

The FDA will also provide recommendations to manufacturers of approved drugs seeking to import into the U.S. versions of those drugs that they sell in other countries. Azar said the pathway stems from discussions regarding the “perverse incentives of the rebate system” in the U.S. The White House abandoned a push to overhaul the drug rebate system earlier this month.

There has been “significant interest from pharmaceutical companies as to whether they could bring product on the market with a different national drug code that would enable lower list prices,” Azar said.

RELATED CONTENT

RELATED VIDEOS

Logistics Global Logistics Sourcing/Procurement/SRM Supply Chain Finance & Revenue Management Global Supply Chain Management Global Trade & Economics Regulation & Compliance Healthcare Pharmaceutical/Biotech North America
KEYWORDS Global Logistics Global Trade & Economics healthcare North America Pharmaceutical/Biotech Regulation & Compliance SC Finance & Revenue Management Sourcing/Procurement/SRM
  • Related Articles

    U.S. Officials Plead for More Use of Languishing Antibody Drugs

    Court Opens Way for U.S. Retailers to Import Lower-Priced Goods Despite Copyright Laws

Bloomberg

Hospitals Ration CT Scans, Awaiting Dye From Shanghai GE Plant

More from this author

Wake up to live
“Supply Chains in Crisis”
updates and the latest Supply Chain News!

Subscribe to our Daily Newsletter

Timely, incisive articles delivered directly to your inbox.

Popular Stories

  • Warehouse worker

    Why Higher Wages Alone Won’t Solve the Supply Chain Labor Shortage

    Warehousing
  • Adidas

    From Sneakers to Teslas, China Lockdowns Upend Global Supply Chains

    Coronavirus
  • Mobile App

    Podcast | Companies Are on a Shopping Spree for Supply Chain Software

    Technology
  • ESG Guide

    Confronting the ESG Imperative in Supply Chains

  • SEC building seal

    Get Ready for the Next Phase of ESG: Mandatory Corporate Due Diligence

    Regulation & Compliance

Digital Edition

Scb feb 2022 sm

2022 Supply Chain Management Resource Guide

VIEW THE LATEST ISSUE

Case Studies

  • 3PL Doubles Productivity With Robots to Fulfill Medical Supply Orders

  • E-Commerce Company Cuts Order Fulfillment Time by 40%

  • Fashion Retailer Halves Fulfillment Time With Omichannel Automation

  • Distributor Scales Business by Integrating Warehouse Automaton Software

  • Fast-Growing Fashion Brand Scales E-Commerce Fulfillment With Whiplash

Visit Our Sponsors

Yang Ming Alithya Barcoding
Blue Yonder BNSF Logistics Generix
GEP GIB USA GreyOrange
Here Honeywell Intelligrated Inmar
Keelvar Kinaxis Korber
Liberty SBF Locus Robotics Lucas Systems
Nvidia Old Dominion Parsyl
Redwood Logistics Saddle Creek Logistics Schneider Dedicated
Setlog Holding AG Ship4WD Shipwell
Tecsys TGW Systems Thomson Reuters
Tive Trailer Bridge Vecna Robotics
Whiplash    
  • More From SCB
    • Featured Content
    • Video Library
    • Think Tank Blog
    • SupplyChainBrain Podcast
    • Whitepapers
    • On-Demand Webinars
    • Upcoming Webinars
  • Digital Offerings
    • Digital Issue
    • Subscribe
    • Manage Your Subscription
    • Newsletters
  • Resources
    • Events Calendar
    • SCB's Great Supply Chain Partners
    • Supplier Directory
    • Case Study Showcase
    • Supply Chain Innovation Awards
    • 100 Great Partners Form
  • SCB Corporate
    • Advertise on SCB.COM
    • About Us
    • Privacy Policy
    • Contact Us
    • Data Sharing Opt-Out

All content copyright ©2022 Keller International Publishing Corp All rights reserved. No reproduction, transmission or display is permitted without the written permissions of Keller International Publishing Corp

Design, CMS, Hosting & Web Development :: ePublishing